Rigel Pharmaceuticals, Inc. (RIGL)
42.17
-1.23
(-2.83%)
USD |
NASDAQ |
Dec 09, 15:04
Rigel Pharmaceuticals Total Liabilities (Quarterly): 124.92M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| Catalyst Pharmaceuticals, Inc. | 131.36M |
| Amicus Therapeutics, Inc. | 638.39M |
| Perspective Therapeutics, Inc. | 52.61M |
| Nektar Therapeutics | 216.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 242.53M |
| Shareholders Equity (Quarterly) | 117.61M |
| Debt to Equity Ratio | 0.5176 |
| Current Ratio | 2.277 |
| Net Debt Paydown Yield | -0.02% |